AMENDMENT NO.1 TO A MANUFACTURING AND SUPPLY AGREEMENTManufacturing and Supply Agreement • May 24th, 2021 • SOPHiA GENETICS SA • Biological products, (no disgnostic substances) • Delaware
WHEREAS The Parties entered into an “Amended and Restated Manufacturing and Supply Agreement” on October 9th, 2018 (the “Main Agreement”);
EXCLUSIVE LICENCE OF PATENTS AND RESULTSSOPHiA GENETICS SA • May 24th, 2021 • Biological products, (no disgnostic substances)
BETWEEN THE UNDERSIGNED, SOPHIA GENETICS SA, a company duly incorporated in accordance with the laws of Switzerland, under registration number CH-550.1.086.569-3 in the Commercial Register of the Canton of Vaud, domiciled at Rue du Centre 172, 1025 St-Sulpice, Switzerland, represented by [**], duly authorised for this purpose and hereinafter referred to as the “Company”;
AMENDMENT No. 1 TO THE SOPHIA GENETICS SA AGREEMENT dated January 19, 2018 (the “Amendment”)Sa Agreement • May 24th, 2021 • SOPHiA GENETICS SA • Biological products, (no disgnostic substances)
Sophia Genetics SA, Rue du Centre 172, CH-1025 Saint-Sulpice, Switzerland a corporation organized under the laws of the Switzerland (“Sophia Genetics SA”);
SOFTWARE SUB-LICENCE AGREEMENT TO SOPHIA GENETICSSoftware Sub-Licence Agreement • May 24th, 2021 • SOPHiA GENETICS SA • Biological products, (no disgnostic substances)
BETWEEN THE UNDERSIGNED, SATT AQUITAINE, Aquitaine Science Transfert, SAS, SIRET number [**], whose head office is located at [**], hereinafter referred to as “SATT Aquitaine” and SOPHiA GENETICS SA, a company duly incorporated under the laws of Switzerland, bearing the registration number CH-550.1.086.569-3 in the Commercial Register of the Canton of Vaud, domiciled at Rue du Centre 172, 1025 St-Sulpice, Switzerland, represented by [**], duly authorised for this purpose, hereinafter referred to as “SOPHiA GENETICS”.
AGREEMENT FOR THE CO-MARKETING OF PRODUCTS AND SERVICESProducts and Services • May 24th, 2021 • SOPHiA GENETICS SA • Biological products, (no disgnostic substances) • New York
WHEREAS SOPHiA seeks to develop algorithms to analyse data associated with Agilent gene panels and sell access to its platform to interpret this data;
AMENDED AND RESTATED MANUFACTURING AND SUPPLY AGREEMENT “Lockdown NGS Panels”Manufacturing and Supply Agreement • May 24th, 2021 • SOPHiA GENETICS SA • Biological products, (no disgnostic substances) • England
OEM SUPPLY AGREEMENT (the “Agreement”)Oem Supply Agreement • May 24th, 2021 • SOPHiA GENETICS SA • Biological products, (no disgnostic substances)
WHEREAS QIAGEN is skilled and experienced in the development, manufacture and marketing of certain amplification technologies including library amplification kits applied for Next Generation Sequencing Technologies for the research and diagnostic markets;
SUPPLY AGREEMENT (the “Agreement”)Supply Agreement • May 24th, 2021 • SOPHiA GENETICS SA • Biological products, (no disgnostic substances) • New York
TWIST BIOSCIENCE CORPORATION, a company constituted under the laws of the State of Delaware, USA, having a place of business at [**] (hereinafter to be referred to as the “Twist”),
